Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Holiferm logo — Transforming industries with sustainable, highly performing...

Holiferm

Transforming industries with sustainable, highly performing biosurfactants derived from fermentation

Founded 2018 United Kingdom Birkenhead, United Kingdom 69 employees Series B Total: $28.67M Biotechnology, Industrial +1

General Information

Company Name Holiferm
Founded Year 2018
Location United Kingdom Birkenhead, United Kingdom +2
Employees 69
Industries Biotechnology, Industrial, Pharmaceutical
Funding Stage Series B
Social

Get notified when Holiferm moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Major Customer Win Aug 05, 2026

Holiferm highlights An'du, one of their first customers and a partner, for their success in getting listed on Holland & Barrett, utilizing Holiferm's circular feedstock.

Get alerts when Holiferm shows new signals

AI Insight

Bounce Watch AI
2 months ago

Holiferm is demonstrating strong strategic momentum through recent product diversification and significant market validation. The launch of an EU Ecolabel-suitable pet care product showcases expansion into eco-conscious consumer segments, while membership in the BioRevolution Coalition solidifies its position within the broader UK bioeconomy. These developments highlight Holiferm's commitment to driving sustainable innovation and commercializing its biosurfactant technology.

Signal Types
Product Launch Partnership Certification Hiring
Strategic Labels
Market Diversification Sustainability Validation Industry Engagement
Next Move: Market Expansion
·
Impact: 8/10
·
Ideal For: Sustainable Industrial Biotech Investors — Series B

About Holiferm

Holiferm, founded in 2018, is an innovative player in the Biotechnology, Industrial, and Pharmaceutical sectors. The company is headquartered in the United Kingdom and specializes in developing and manufacturing green and sustainable biosurfactants through fermentation.

With its 1.6 ktonne scale manufacturing plant in Liverpool and a research and development facility in Manchester, Holiferm is geared to cater to manufacturing and development needs worldwide. Their comprehensive support system aids client integration of these biosurfactants into various formulations, fulfilling their mission of "Transforming industries with sustainable, highly performing biosurfactants derived from fermentation."

The company's promising trajectory was further validated by securing a substantial £18.50M in a Series B round on 01 January 2024, with the participation of notable investors such as Rhapsody Venture Partners and the Clean Growth Fund.

Taxonomy: sustainable biosurfactants, biosurfactant manufacturing, fermentation processes, green chemistry, environmental technology, R&D facility, sophorolipid production, industrial biotechnology, customer technical support, innovation in surfactants, clean technology, specialty chemicals

Services & Products

Development of sustainable and advanced biomanufactured ingredients
Collaboration with brands for customized formulations
Biomanufacturing with reduced CO₂ emissions and energy use

Target Customers

Personal care brands Home care product developers Agricultural solution providers Eco-conscious manufacturers

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 2
Investor Investor
01 Jan 2024
Early VC •••••• 1
Investor
01 Jul 2023
Early VC •••••• 1
Investor
01 Oct 2021
Grant •••••• - 01 Jan 2020
Grant •••••• 1
Investor
01 Jul 2019

View All 7 Funding Rounds

Holiferm Alternatives & Competitors

View All Alternatives
Holiferm vs
Dispersa
Dispersa Canada

Transforming waste into biosurfactants.

Debt Financing
12 employees
Biotechnology
Compare Holiferm vs Dispersa
Holiferm vs
GlycoSurf, Inc.
GlycoSurf, Inc. United States

Inspired by Nature

Grant
10 employees
Manufacturing
Compare Holiferm vs GlycoSurf, Inc.
Holiferm vs
KREATIZE GmbH
KREATIZE GmbH Germany

WE ARE HIRING! At KREATIZE our vision is to accelerate innovation that changes the world.

Series A
3 employees
IT, Information Technology
Compare Holiferm vs KREATIZE GmbH
View all alternatives

FAQ About Holiferm

Transforming industries with sustainable, highly performing biosurfactants derived from fermentation
Holiferm was founded in 2018.
Holiferm is headquartered in Birkenhead, United Kingdom.
Holiferm operates in the following industries: Biotechnology, Industrial, Pharmaceutical.
Holiferm has approximately 69 employees.
Holiferm has completed 7 funding rounds, raising a total of $28.67M. The latest funding stage is Series B.
Holiferm offers: Development of sustainable and advanced biomanufactured ingredients, Collaboration with brands for customized formulations, Biomanufacturing with reduced CO₂ emissions and energy use.
Top alternatives and competitors to Holiferm include Dispersa, GlycoSurf, Inc., KREATIZE GmbH, Pressure Chemical Co., EIT Manufacturing. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Holiferm and Dispersa are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Holiferm and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy